At The Regulatory Review, Prof. Allison K. Hoffman discusses the role of state ballot initiatives, federal law, and private equity in the U.S. health care system.
At The Regulatory Review, Prof. Tess Wilkinson-Ryan L’05, G’06, PhD’08 discusses the role of human psychology in legal and regulatory systems.
Prof. Cary Coglianese writes, “Analyzing and improving compliance is the key to strengthening regulators’ performance.”
“States should prohibit local zoning ordinances that bar affordable, climate-friendly housing,” writes Bryn Hines L’24.
Regulators should factor in the dynamic nature of machine learning when proposing AI regulations, writes Prof. Cary Coglianese.
At The Regulatory Review, Soojin Jeong L’23 advocates for algorithmic impact assessments (AIA) as a tool to promote accountability without sacrificing regulatory flexibility that supports innovation.
In a new study, Prof. Cary Coglianese and co-author demonstrate the power of businesses to exert substantial influence over agency rulemaking.
At The Regulatory Review, Caroline Hackley L’24 examines the limitations of COPPA, the only federal law regulating the collection of children’s data via the internet.
Prof. Christopher S. Yoo and Bethany Lee L’22 advocate FDA regulatory action to better address cybersecurity risks of medical devices such as pacemakers.
Prof. Cary Coglianese proposes statutory revisions aimed at increasing online accessibility of federal agencies’ legal materials.
Prof. Cary Coglianese discusses how regulators can sharpen their skills and produce better regulatory outcomes.
At The Regulatory Review, Janaina Rodrigues Valle Gomes LLM’23 explores policy recommendations proposed by Rangita de Silva de Alwis and other scholars to ensure equity in AI development.
At The Regulatory Review, Prof. Shelley Welton examines opportunities to strengthen the OMB’s revised guidance on regulatory analysis.
Leading lawyers and scholars examine the Supreme Court’s major regulatory decisions from its recent term.
At The Regulatory Review, Cara McClellan GEd’12 explains what’s left and what’s next for racial diversity in college admissions after the Supreme Court’s recent affirmative action decision.
Madeline Bruning L’24 examines state and federal responses to shore up fragile septic infrastructure and curb public health risks.
At The Regulatory Review, Katie Cohen L’24, MBE’24 explores the complexities of and continued barriers to increasing access to over-the-counter treatment for opioid overdose.
“Both the congressional resolution and the presidential veto represent a contentious battle,” writes Alexandra Walsh L’24, WG’26 for The Regulatory Review.
“[G]reater overall access masks the realities and stakes of air travel for people with disabilities,” writes Prof. Jasmine Harris at The Regulatory Review.
At The Regulatory Review, William McDonald L’24 explores the perspective that foreign student-athletes must currently choose between earning money and keeping their immigration status.
At The Regulatory Review, Evelyn Tsisin L’24, GR’24 argues that the FDA — not courts — should decide on the safety of abortion drugs.
At The Regulatory Review, Nabil Shaikh L’24 explores the perspective that Congress and the FDA should treat risky clinical artificial intelligence tools as medical devices.
“The legal ambiguity of art created by artificial intelligence adds confusion to controversy,” writes Elizabeth Penava L’23 at The Regulatory Review.
Prof. Michael Knoll explores the potential ramifications of National Pork Producers Council v. Ross in The Regulatory Review.